AN2 Therapeutics Stock (NASDAQ: ANTX) stock price, news, charts, stock research, profile.
Open | $1.07 |
Close | $1.08 |
Volume / Avg. | 384.42K / 596.75K |
Day Range | $1.05 - $1.08 |
52 Wk Range | 0.87 - 22.22 |
Market Cap | $31.33M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 31 |
Short Interest | 0.76% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of AN2 Therapeutics (NASDAQ:ANTX) through any online brokerage.
Other companies in AN2 Therapeutics’s space includes: Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), Cocrystal Pharma (NASDAQ:COCP), SCYNEXIS (NASDAQ:SCYX) and CalciMedica (NASDAQ:CALC).
AN2 Therapeutics has a consensus price target of $13.00.
The stock price for AN2 Therapeutics (NASDAQ: ANTX) is $1.05 last updated September 19, 2024 at 5:43 PM EDT.
A quarterly cash dividend of 0.66 per share of Class A Common Stock. The quarterly cash dividend was payable on February 1, 2018 to stockholders of record on January 11, 2018.
AN2 Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for AN2 Therapeutics.
AN2 Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.